Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ricklin

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Molecular Immunology|May 6, 2008
Dynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometryMichael C Schuster, Daniel Ricklin, Krisztián Papp, et al.
Chemmedchem|August 4, 2020
A Potent Mimetic of the Siglec-8 Ligand 6'-Sulfo-Sialyl Lewis<sup>x</sup>Blijke S Kroezen, Gabriele Conti, Benedetta Girardi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 6, 2024
Humanization of <i>SLCO2B1</i> in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, et al.
Iscience|November 18, 2020
Intracellular C4BPA Levels Regulate NF-κB-Dependent ApoptosisMonica M Olcina, Ryan K Kim, Nikolas G Balanis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2015
Comparative Analysis of Novel Complement-Targeted Inhibitors, MiniFH, and the Natural Regulators Factor H and Factor H-like Protein 1 Reveal Functional Determinants of Complement RegulationMarkus J Harder, Markus Anliker, Britta Höchsmann, et al.
Pharmacology Research & Perspectives|June 20, 2025
Insights Into Atorvastatin Pharmacokinetics in Rats Reveal Regulation of CYP3A1 by Humanization of SLCO2B1Jonny Kinzi, Janine Hussner, Isabell Seibert, et al.
The Journal of Biological Chemistry|November 17, 2011
Diversity in the C3b [corrected] contact residues and tertiary structures of the staphylococcal complement inhibitor (SCIN) protein familyBrandon L Garcia, Brady J Summers, Zhuoer Lin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 20, 2016
Method development and validation for the quantitation of the complement inhibitor Cp40 in human and cynomolgus monkey plasma by UPLC-ESI-MSAlexandra Primikyri, Malvina Papanastasiou, Yiannis Sarigiannis, et al.
Scientific Reports|May 16, 2026
Production and characterization of gigastasin, a leech-derived inhibitor of complement and coagulation pathwaysAleksandra Blagojevic, Peter Rüthemann, Kevin Widmer, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 18, 2023
Simultaneous quantification of atorvastatin, erlotinib and OSI-420 in rat serum and liver microsomes using a novel liquid chromatography-mass spectrometry methodMarta A Rysz, Jonny Kinzi, Anima M Schäfer, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Molecular Immunology|May 6, 2008
Dynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometryMichael C Schuster, Daniel Ricklin, Krisztián Papp, et al.
Chemmedchem|August 4, 2020
A Potent Mimetic of the Siglec-8 Ligand 6'-Sulfo-Sialyl Lewis<sup>x</sup>Blijke S Kroezen, Gabriele Conti, Benedetta Girardi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 6, 2024
Humanization of <i>SLCO2B1</i> in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420Marta Rysz, Anima M Schäfer, Nikolaos Paloumpis, et al.
Iscience|November 18, 2020
Intracellular C4BPA Levels Regulate NF-κB-Dependent ApoptosisMonica M Olcina, Ryan K Kim, Nikolas G Balanis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2015
Comparative Analysis of Novel Complement-Targeted Inhibitors, MiniFH, and the Natural Regulators Factor H and Factor H-like Protein 1 Reveal Functional Determinants of Complement RegulationMarkus J Harder, Markus Anliker, Britta Höchsmann, et al.
Pharmacology Research & Perspectives|June 20, 2025
Insights Into Atorvastatin Pharmacokinetics in Rats Reveal Regulation of CYP3A1 by Humanization of SLCO2B1Jonny Kinzi, Janine Hussner, Isabell Seibert, et al.
The Journal of Biological Chemistry|November 17, 2011
Diversity in the C3b [corrected] contact residues and tertiary structures of the staphylococcal complement inhibitor (SCIN) protein familyBrandon L Garcia, Brady J Summers, Zhuoer Lin, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 20, 2016
Method development and validation for the quantitation of the complement inhibitor Cp40 in human and cynomolgus monkey plasma by UPLC-ESI-MSAlexandra Primikyri, Malvina Papanastasiou, Yiannis Sarigiannis, et al.
Scientific Reports|May 16, 2026
Production and characterization of gigastasin, a leech-derived inhibitor of complement and coagulation pathwaysAleksandra Blagojevic, Peter Rüthemann, Kevin Widmer, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 18, 2023
Simultaneous quantification of atorvastatin, erlotinib and OSI-420 in rat serum and liver microsomes using a novel liquid chromatography-mass spectrometry methodMarta A Rysz, Jonny Kinzi, Anima M Schäfer, et al.
Pageof 14